
Currently out of the existing stock ratings of Florent Cespedes, 7 are a HOLD (46.67%), 5 are a BUY (33.33%), 3 are a SELL (20%).
Analyst Florent Cespedes, currently employed at SOCGEN, has had 62.5% of price targets met with an average potential upside of 17.62%, reached in 417 days on average. Previously, Florent Cespedes worked at JEFFERIES.
Florent Cespedes has documented 23 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 09-Sep-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) on 11/3/2020. The price target of $30.79 was fulfilled within 2 days with a profit of $2.26 (7.92%), with a performance score of 39.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Feb-2026
$1550
$106.5 (7.38%)
$1400
1 days ago
(15-Nov-2026)
Buy Since 26-Feb-2020
$1600
$156.5 (10.84%)
$1440
15 days ago
(01-Nov-2026)
37/39 (94.87%)
$189.01 (13.40%)
124
Buy Since 16-Nov-2022
$1600
$156.5 (10.84%)
$1500
18 days ago
(29-Oct-2026)
21/24 (87.5%)
$182.46 (12.87%)
135
Buy Since 17-Mar-2023
$1500
$56.5 (3.91%)
$1330
18 days ago
(29-Oct-2026)
26/27 (96.3%)
$82.46 (5.82%)
135
Buy Since 07-Jan-2025
$1612
$168.5 (11.67%)
$1281
18 days ago
(29-Oct-2026)
8/9 (88.89%)
$194.46 (13.72%)
238
What Year was the first public recommendation made by Florent Cespedes?